Scientists at King Abdullah University of Science and Technology (KAUST) have developed a new stain-free imaging platform using engineered silicon slides to analyze tissue samples, aiming for quicker and more consistent cancer diagnostics. This platform removes the need for conventional chemical staining, reducing preparation time by approximately 40-50% and improving consistency. In validation tests with 120 colorectal tissue samples, the technology achieved a 99% agreement rate with traditional pathology assessments. Why it matters: This innovation could significantly streamline cancer diagnosis workflows, reduce variability, and generate standardized data crucial for the advancement of AI-assisted diagnostic tools in healthcare.
M42, a UAE-based healthcare company, has launched an AI-powered tool specifically designed for prostate cancer diagnosis. The technology aims to enhance the accuracy and efficiency of detecting prostate cancer, potentially improving patient outcomes through earlier intervention. This diagnostic solution represents a step forward in integrating artificial intelligence into clinical practice within the region. Why it matters: This development signifies a notable advancement in the application of AI in healthcare in the UAE, potentially positioning the country as a leader in medical AI innovation and improving public health.
MBZUAI researchers are refining AI techniques to improve cancer diagnosis for colorectal and breast cancer, both common in the Middle East. They are using "few-shot tissue image generation," in which AI generates data for training AI models to recognize lesions, addressing the challenge of limited training data. The developed framework improves the efficiency of radiologists in breast cancer diagnosis, leading to better detection of breast lesions and timely treatment interventions. Why it matters: These advancements in AI-aided diagnostics can lead to earlier and more accurate cancer detection, ultimately improving patient outcomes in the region and beyond.
MBZUAI's first Ph.D. graduate, Numan Saeed, developed deep learning models to diagnose head and neck cancers using PET and CT scan imagery. His research focused on improving early detection and accurate localization of tumors, aiming to enhance diagnosis and prognosis. Early diagnosis can reduce mortality rates by up to 70%. Why it matters: This research showcases the potential of AI in healthcare to improve cancer diagnosis and treatment, addressing a critical need in resource-constrained healthcare systems.
MBZUAI awarded its first Ph.D. to Numan Saeed for his dissertation, "Deep Learning for Cancer Diagnosis and Prognosis." Saeed's research explores using deep learning models to diagnose tumors and predict survival rates for head and neck cancers by interpreting PET and CT scan imagery and doctor's notes. The AI model considers variables like age, gender, and tumor size to improve diagnosis, especially in regions with limited oncological services. Why it matters: This milestone highlights MBZUAI's growing role in AI research and its potential to contribute to advancements in AI-driven healthcare solutions, particularly for cancer diagnosis and treatment.
MBZUAI master's student Sayed Hashim is applying machine learning to improve cancer diagnosis and treatment, motivated by personal loss. He and fellow student Muhammad Ali developed algorithms for cancer type classification from multi-omics data, achieving over 96% accuracy. Their work, supervised by MBZUAI faculty, resulted in a published paper on multi-omics data representation learning. Why it matters: This research demonstrates the potential of AI and machine learning to advance cancer research and personalized medicine in the region.
MBZUAI students and researchers presented findings at the Graduate Student Research Conference (GSRC) in Dubai, led by Assistant Professor Mohammad Yaqub. Topics included deep learning, computer learning, disease prediction, and AI in healthcare, with students from the BioMedIA lab presenting their work. Presentations covered areas like fetal ultrasound quality assessment, head and neck cancer diagnosis, and disease risk prediction using generative pre-trained transformers. Why it matters: This showcases MBZUAI's focus on applying AI to solve real-world healthcare problems and highlights the contributions of its students in advancing medical AI research.